Docebo Inc. (DCBO) Stock Price & Analysis
Docebo Inc. (DCBO) closed at USD 29.71 on Wednesday, October 28, 2026, up 0.29% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 29.62; the Oct 28, 2026 session ranged USD 28.76–30.37 on volume of 45,642 shares. Market capitalization is $741.07M, with a 52-week range of USD 14.39–31.27 (NMS). Source: Nexqual, retrieved October 29, 2026 at 12:40 UTC.
Also available as compact Markdown for AI agents: nexqual.com/DCBO.md
Key facts (DCBO)
- Analysts: Buy (mean 1.73 on a 1–5 scale) (11 analysts), mean target USD 29.93 (range 25–38).
- Total return with dividends: 1Y +16.0% vs S&P 500 +13.6%; 5Y -60.4% vs S&P 500 +79.8%.
- Next earnings: 2026-11-06, EPS estimate USD 0.47, revenue estimate $69.6M.
Analysts (DCBO)
Consensus Buy (mean 1.73 on a 1–5 scale), 11 analysts; mean target USD 29.93 (low 25, high 38).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-17 | Needham | Reiterated | Buy | $31 |
Total return (dividends reinvested) (DCBO)
| 1Y (from 2025-10-29) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +16.0% | -60.4% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | +16.1% | -16.9% |
| Volatility (annualized) | 57.1% | 51.7% |
| Max drawdown | -42.6% (Nov 2025→Apr 2026) | -80.9% (Nov 2021→Apr 2026) |
DCBO major shareholder filing: Schedule 13D/A, Jul 20, 2026
Jason Chapnik, Intercap Inc. filed a Schedule 13D/A with the SEC on Jul 20, 2026, reporting up to 64.00% of the class. A Schedule 13D is filed by an owner of more than 5% who may seek to influence the company. Item 4 (Purpose of Transaction), quoted from the filing:
Item 4 of the Statement is hereby amended and supplemented as follows: On July 17, 2026, the Issuer announced that its board of directors has approved a substantial issuer bid (the "Offer") under which the Company will offer to repurchase for cancellation up to US$70,000,000 of its outstanding Common Shares at a price of US$20.40 per Common Share. Intercap has informed the Company that it intends to participate in the Offer in a manner consistent with maintaining at least its current level of ownership on a percent of outstanding Common Shares basis. However, Intercap's decision to participate in the Offer is subject to market conditions and other factors and Intercap reserves the right to change its intentions at any time. Intercap's percentage ownership interest in the Company may increase as a result of the Offer.
Source: SEC EDGAR, Schedule 13D/A filed Jul 20, 2026. Quoted word for word; Nexqual adds no interpretation.
DCBO earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.35 | $0.29 | Beat +20.7% | — |
| — | Quarter ended Mar 31, 2026 | $0.34 | $0.35 | Miss −2.9% | — |
| — | Quarter ended Dec 31, 2025 | $0.45 | $0.36 | Beat +25.0% | — |
| — | Quarter ended Sep 30, 2025 | $0.34 | $0.33 | Beat +3.0% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
DCBO recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Sep 11, 2026 | 6-K | Current report (foreign issuer) · period ended Sep 11, 2026 |
| Sep 9, 2026 | 6-K | Current report (foreign issuer) · period ended Sep 9, 2026 |
| Aug 21, 2026 | 6-K | Current report (foreign issuer) · period ended Aug 21, 2026 |
| Aug 7, 2026 | 6-K | Current report (foreign issuer) · period ended Jun 30, 2026 |
| Jul 21, 2026 | 6-K | Current report (foreign issuer) · period ended Jul 21, 2026 |
| Jul 20, 2026 | Schedule 13D/A | Jason Chapnik, Intercap Inc.: 64.0% of shares, 5%+ holder that may seek to influence the company (amended) “Item 4 of the Statement is hereby amended and supplemented as follows: On July 17, 2026, the Issuer announced that its board of directors has approved a substantial issuer bid (the "Offer") under which the Company will offer to repurchase for cancellation up to US$70,000,000 of…” |
| Jul 17, 2026 | 6-K | Current report (foreign issuer) · period ended Jul 17, 2026 |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
DCBO analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.47 | $0.47 | +0.1% | $69.6M | 7 |
| Next quarter (ends Dec 2026) | $0.54 | $0.51 | +6.9% | $71.7M | 5 |
| Current fiscal year (ends Dec 2026) | $1.69 | $1.61 | +5.1% | $275.5M | 9 |
| Next fiscal year (ends Dec 2027) | $2.09 | $2.01 | +4.2% | $303.3M | 8 |
DCBO options: expected move
Options price a move of about ±11.4% (±$3.38) by Nov 20, 2026, which includes earnings on Nov 6, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 22 | 56.4% | ±11.4% |
| Feb 19, 2027 | 113 | 48.2% | ±21.0% |
| May 21, 2027 | 204 | 50.9% | ±29.8% |
30-day implied volatility 57.9% vs 38.5% realized over the last 30 trading days. Put/call ratio (volume) 10. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 29, 2026 at 12:40 UTC)
| Price | USD 29.71 |
|---|---|
| Change | ▲ 0.29% (up) |
| Previous Close | USD 29.62 |
| Open | USD 29.58 |
| Day Range | USD 28.76 – 30.37 |
| 52-Week Range | USD 14.39 – 31.27 |
| Volume | 45,642 shares |
| Market Cap | $741.07M |
| Exchange | NMS |
Technical Analysis (DCBO)
Nexqual's technical model rates DCBO "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 29, 2026 at 12:40 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 67.07 (neutral) |
| vs SMA50 | Above (USD 25.32) |
| MACD | 1.73 (positive) |
Analyst Ratings (DCBO)
Wall Street analysts rate DCBO "Buy" based on 11 analysts, with a mean price target of USD 29.93 (range USD 25–38), per Nexqual as of October 29, 2026 at 12:40 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 29.93 |
| High Target | USD 38 |
| Low Target | USD 25 |
| Buy / Hold / Sell | 10 / 1 / 0 |
Earnings (DCBO)
| Next Earnings Date | 2026-11-06 |
|---|---|
| EPS Estimate | USD 0.47 |
| Revenue Estimate | $69.60M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.35 vs est 0.29 ▲ beat |
| 2026-03-31 | USD 0.34 vs est 0.35 ▼ miss |
| 2025-12-31 | USD 0.45 vs est 0.36 ▲ beat |
| 2025-09-30 | USD 0.34 vs est 0.33 ▲ beat |
Source: Nexqual, October 29, 2026 at 12:40 UTC.
Financials & Fundamentals (DCBO)
| Total Revenue | $258.93M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +13.00% |
| Gross Margin | +79.64% |
| Operating Margin | +9.11% |
| Profit Margin | +12.98% |
| ROE | +195.48% |
| Current Ratio | 0.83 |
| Total Cash | $45.72M |
| Total Debt | $93.77M |
Source: Nexqual, October 29, 2026 at 12:40 UTC.
Financial Health Score (DCBO)
Nexqual rates Docebo Inc.'s overall financial health "Solid" across five dimensions, as of October 29, 2026 at 12:40 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 80%, operating 9% (last 12 months) |
| Balance Sheet | Mixed — $46M cash vs $94M debt |
| Cash Flow | Solid — Operating cash flow $36M (TTM) |
| Efficiency | Strong — ROE 195%, ROA 10.5% |
Ownership (DCBO)
| Insider Ownership | +64.42% |
|---|---|
| Institutional Ownership | +23.48% |
| Shares Outstanding | 24.95M |
| Float | 8.75M |
Source: Nexqual, October 29, 2026 at 12:40 UTC.
Leadership (DCBO)
Docebo Inc. is led by Alessio Artuffo, CEO, President & Director, per Nexqual as of October 29, 2026 at 12:40 UTC.
| CEO, President & Director | Alessio Artuffo |
|---|---|
| Chief Financial Officer | Brandon Farber |
| Chief Marketing Officer | Kyle Lacy |
| Chief Revenue Officer | Mark Kosoglow |
| Chief Technology Officer | Riccardo LaRosa |
Major Backers & Investors (DCBO)
Notable institutional backers of Docebo Inc. include Beutel, Goodman & Company Ltd, Topline Capital Management, LLC, Arrowstreet Capital, Limited Partnership, according to Nexqual as of October 29, 2026 at 12:40 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Beutel, Goodman & Company Ltd | 6.17% |
| Topline Capital Management, LLC | 2.65% |
| Arrowstreet Capital, Limited Partnership | 2.48% |
| Quadrature Capital Ltd | 1.18% |
| Sparta 24 Ltd. | 0.8% |
| Two Sigma Investments, LP | 0.78% |
| Essex Investment Management Co LLC | 0.64% |
| Morgan Stanley | 0.57% |
Source: Nexqual, October 29, 2026 at 12:40 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RNG | Ringcentral, Inc. | USD 86.2 | ▲ 0.7% |
| APPF | AppFolio, Inc. | USD 205 | ▲ 1.76% |
| TTAN | ServiceTitan, Inc. | USD 80.86 | ▼ 0.93% |
| DSGX | The Descartes Systems Group Inc | USD 92.36 | ▲ 0.2% |
| IDCC | InterDigital, Inc. | USD 320.56 | ▼ 2.51% |
| YMM | Full Truck Alliance Co. Ltd. | USD 8.08 | ▼ 4.04% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 12:40 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt